FDA Generic Drugs Division probe
Executive Summary
In its account July 11 of Rep. Dingell's probe of possible improprieties in the Generic Drug Division's ANDA approval procedures, "The Pink Sheet" identified five staffers who had been the subject of a previous investigation in 1980. Two of those involved in the 1980 probe -- reviewers Mary Jarski and Geraldine Millar -- have since departed from the Generic Drugs Division and have no connection to the current Dingell review.